Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency

Astrid C van Stigt; Virgil A S H Dalm; Nicole M A Nagtzaam; P Martin van Hagen; Willem A Dik; Hanna IJspeert

doi:10.1007/s10875-023-01560-1

Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency

J Clin Immunol. 2023 Nov;43(8):1754-1757. doi: 10.1007/s10875-023-01560-1. Epub 2023 Aug 5.

Authors

Astrid C van Stigt^{1

2

3}, Virgil A S H Dalm^{1

2

3}, Nicole M A Nagtzaam^{1

3}, P Martin van Hagen^{1

2

3}, Willem A Dik^#^{1

3}, Hanna IJspeert^#^{4

5}

Affiliations

¹ Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, Department of Immunology, Rotterdam, The Netherlands.
² Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, Division of Allergy & Clinical Immunology, Rotterdam, The Netherlands.
³ Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), Rotterdam, The Netherlands.
⁴ Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, Department of Immunology, Rotterdam, The Netherlands. h.ijspeert@erasmusmc.nl.
⁵ Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), Rotterdam, The Netherlands. h.ijspeert@erasmusmc.nl.

^# Contributed equally.

No abstract available

Publication types

Letter

MeSH terms

Common Variable Immunodeficiency*
Disease Progression
Humans